Bentley Pharmaceuticals RSS Feed | Nachrichten - www.finanzen.net

Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share

Bentley Pharmaceuticals, Inc. ("Bentley�) (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva�) has been adjusted in accordance with the merger agreement after ...

CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals

CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc. (NYSE: BNT) yesterday at 11:59 p.m. Shares of the new company will begin regular trading today on the ...

Bentley Pharmaceuticals Completes Spin-off of Drug Delivery Business

Bentley Pharmaceuticals, Inc. (NYSE: BNT) completed the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) yesterday at 11:59 p.m. Each Bentley stockholder received, on a ...

Bentley Board Approves Spin-off of Drug Delivery Business

The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business into a new publicly traded company to be called CPEX Pharmaceuticals, Inc. CPEX is a drug delivery company ...

Bentley Pharmaceuticals Announces First Quarter Financial Results

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the first quarter and three months ended March 31, 2008. First quarter 2008 revenues were $40.0 million, a 27% ...

Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss first-quarter 2008 financial results on Thursday, May 8, 2008, at 10:00 a.m. (ET). ...

Teva k�ndigt �bernahme von Bentley Pharmaceuticals an

Petach Tikva (aktiencheck.de AG) - Der israelische Generikahersteller Teva Pharmaceutical Industries Ltd. (Teva Pharmaceuticals Industries) will seine Marktposition durch eine Akquisition verstärken. ...

Teva to Acquire Bentley Pharmaceuticals

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which Teva will acquire Bentley. The acquisition will take place ...

Bentley Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2007. Fourth quarter 2007 revenues were $34.8 million, a 29% increase ...

Bentley Pharmaceuticals to Release Fourth-Quarter 2007 Financial Results on March 13, 2008

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss fourth-quarter and year-end 2007 financial results on Thursday, March 13, 2008, ...